Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Webinars / 2023 / Addressing the incomplete mutational landscape in pediatric cancers with Optical Genome Mapping
Bionano Subspecialties Oncology Omics

Addressing the incomplete mutational landscape in pediatric cancers with Optical Genome Mapping

In this Bionano in Motion webinar, we explore the utility and validity of an innovative strategy, proposed by Dr Brandes from Heinrich-Heine University and University Hospital Dusseldorf that combines Optical Genome Mapping (OGM) and whole exome sequencing (WES) in 60 HD and ETV6::RUNX1+ BCP-ALL cases. This study shows that OGM detected a high number of additional SVs not identified using the conventional methods, including (subclonal) IKZF1 deletions, a prognostically relevant subtype.

10/30/2023 11am ET

Share

Register here

October 30, 2023 - 11am ET

In this Bionano in Motion webinar, we explore the utility and validity of an innovative strategy, proposed by Dr Brandes from Heinrich-Heine University and University Hospital Dusseldorf that combines Optical Genome Mapping (OGM) and whole exome sequencing (WES) in 60 HD and ETV6::RUNX1+ BCP-ALL cases. This study shows that OGM detected a high number of additional SVs not identified using the conventional methods, including (subclonal) IKZF1 deletions, a prognostically relevant subtype. 

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

More Webinars

Subspecialties Oncology

December 18, 2023

The pathologist's impact on clinical practice & patients' lives

Diagnostics Oncology Genetics and epigenetics

November 30, 2023

Rapid molecular profiling is essential to optimize patient outcomes - Real-world data analysis

Diagnostics Oncology Genetics and epigenetics

December 11, 2023

Multicenter study of the Oncomine Comprehensive Assay Plus for local comprehensive molecular profiling

False

Advertisement

Recommended

False

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.